Hepatitis E laboratory tests: Difference between revisions
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
| Line 16: | Line 16: | ||
! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Findings}} | ! style="width: 200px; background: #4479BA; text-align: center;"| {{fontcolor|#FFF|Findings}} | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| ''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Incubation period''' | ||
| style="background: #DCDCDC; padding: 5px;"| | | style="background: #DCDCDC; padding: 5px;"| | ||
*Rise of [[viremia]] | *Rise of [[viremia]] | ||
*Detection of [[HEV]] in stool | *Detection of [[HEV]] in stool | ||
|- | |- | ||
| style="background: #F5F5F5; padding: 5px; text-align: center;"| ''' | | style="background: #F5F5F5; padding: 5px; text-align: center;"| '''Symptom onset''' | ||
| style="background: #DCDCDC; padding: 5px;"| | | style="background: #DCDCDC; padding: 5px;"| | ||
*[[IgM]] and [[IgG]] antibody detection | *[[IgM]] and [[IgG]] antibody detection | ||
*Elevations on serum [[aminotransferase]] and [[symptom]] onset | *Elevations on serum [[aminotransferase]] ([[ALT]], [[AST]] and [[symptom]] onset | ||
*[[HEV]] detected in stool | *[[HEV]] detected in stool | ||
|- | |- | ||
| Line 41: | Line 41: | ||
Immunocompromised patients may have a delayed immune response to HEV, and hence delayed seroconversion. Therefore, these patients should be tested for HEV RNA.<ref name="pmid19866448">{{cite journal| author=Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N et al.| title=Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. | journal=Liver Transpl | year= 2010 | volume= 16 | issue= 1 | pages= 74-82 | pmid=19866448 | doi=10.1002/lt.21958 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19866448 }} </ref> The RNA of the virus may be detected in blood and stool for several weeks, and quantified in order to evaluate response to treatment<ref name="pmid22537448">{{cite journal| author=Wedemeyer H, Pischke S, Manns MP| title=Pathogenesis and treatment of hepatitis e virus infection. | journal=Gastroenterology | year= 2012 | volume= 142 | issue= 6 | pages= 1388-1397.e1 | pmid=22537448 | doi=10.1053/j.gastro.2012.02.014 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22537448 }} </ref><ref name="pmid21307208">{{cite journal| author=Baylis SA, Hanschmann KM, Blümel J, Nübling CM, HEV Collaborative Study Group| title=Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. | journal=J Clin Microbiol | year= 2011 | volume= 49 | issue= 4 | pages= 1234-9 | pmid=21307208 | doi=10.1128/JCM.02578-10 | pmc=PMC3122834 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21307208 }} </ref> | Immunocompromised patients may have a delayed immune response to HEV, and hence delayed seroconversion. Therefore, these patients should be tested for HEV RNA.<ref name="pmid19866448">{{cite journal| author=Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N et al.| title=Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. | journal=Liver Transpl | year= 2010 | volume= 16 | issue= 1 | pages= 74-82 | pmid=19866448 | doi=10.1002/lt.21958 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19866448 }} </ref> The RNA of the virus may be detected in blood and stool for several weeks, and quantified in order to evaluate response to treatment<ref name="pmid22537448">{{cite journal| author=Wedemeyer H, Pischke S, Manns MP| title=Pathogenesis and treatment of hepatitis e virus infection. | journal=Gastroenterology | year= 2012 | volume= 142 | issue= 6 | pages= 1388-1397.e1 | pmid=22537448 | doi=10.1053/j.gastro.2012.02.014 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22537448 }} </ref><ref name="pmid21307208">{{cite journal| author=Baylis SA, Hanschmann KM, Blümel J, Nübling CM, HEV Collaborative Study Group| title=Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. | journal=J Clin Microbiol | year= 2011 | volume= 49 | issue= 4 | pages= 1234-9 | pmid=21307208 | doi=10.1128/JCM.02578-10 | pmc=PMC3122834 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21307208 }} </ref> | ||
The following tests are done to identify and monitor liver damage from hepatitis B: | The following tests are done to identify and monitor liver damage from hepatitis B: | ||
Revision as of 13:33, 26 August 2014
|
Hepatitis E Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Hepatitis E laboratory tests On the Web |
|
American Roentgen Ray Society Images of Hepatitis E laboratory tests |
|
Risk calculators and risk factors for Hepatitis E laboratory tests |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. [2] João André Alves Silva, M.D. [3]
Overview
Laboratory Findings
Every patient with acute or chronic hepatitis, which cannot be explained by other causes, should be tested for hepatitis E.[1] Unfortunately, the different available assays show different specificity and sensitivity, and are only available at certain centers.[2]
Throughout the course of infection, serologic markers will vary according to the stage of the disease:[2]
| Test | Findings |
|---|---|
| Incubation period | |
| Symptom onset | |
| Recovery |
The detection of increased levels of anti-HEV IgG may therefore indicate recent HEV infection.[1] Several assays are based on the HEV genotype, therefore, even though the specificity may be high, sensitivity of different tests for the remaining genotypes may be lower.[1]
Immunocompromised patients may have a delayed immune response to HEV, and hence delayed seroconversion. Therefore, these patients should be tested for HEV RNA.[3] The RNA of the virus may be detected in blood and stool for several weeks, and quantified in order to evaluate response to treatment[1][4]
The following tests are done to identify and monitor liver damage from hepatitis B:
- Albumin level
- Liver function tests
- Prothrombin time
- Antibody test
Since cases of hepatitis E are not clinically distinguishable from other types of acute viral hepatitis, diagnosis is made by blood tests which detect elevated antibody levels of specific antibodies to hepatitis E in the body or by reverse transcriptase polymerase chain reaction (RT-PCR). Unfortunately, such tests are not widely available.
Hepatitis E should be suspected in outbreaks of waterborne hepatitis occurring in developing countries, especially if the disease is more severe in pregnant women, or if hepatitis A has been excluded. If laboratory tests are not available, epidemiologic evidence can help in establishing a diagnosis.
References
- ↑ 1.0 1.1 1.2 1.3 Wedemeyer H, Pischke S, Manns MP (2012). "Pathogenesis and treatment of hepatitis e virus infection". Gastroenterology. 142 (6): 1388–1397.e1. doi:10.1053/j.gastro.2012.02.014. PMID 22537448.
- ↑ 2.0 2.1 Hoofnagle JH, Nelson KE, Purcell RH (2012). "Hepatitis E." N Engl J Med. 367 (13): 1237–44. doi:10.1056/NEJMra1204512. PMID 23013075.
- ↑ Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N; et al. (2010). "Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients". Liver Transpl. 16 (1): 74–82. doi:10.1002/lt.21958. PMID 19866448.
- ↑ Baylis SA, Hanschmann KM, Blümel J, Nübling CM, HEV Collaborative Study Group (2011). "Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance". J Clin Microbiol. 49 (4): 1234–9. doi:10.1128/JCM.02578-10. PMC 3122834. PMID 21307208.